Vitiligo

Latest News

Oral Ritlecitinib Plus nbUV-B Accelerates Repigmentation in Nonsegmental Vitiligo
Oral Ritlecitinib Plus nbUV-B Accelerates Repigmentation in Nonsegmental Vitiligo

June 17th 2025

Discover promising advancements in vitiligo treatments, including innovative therapies and combination approaches that enhance skin repigmentation and improve patient quality of life.

Five Clinical Subtypes Identified in Vitiligo Cohort
Five Clinical Subtypes Identified in Vitiligo Cohort

June 12th 2025

Integrating Ruxolitinib, Excimer Laser, and Emerging Therapies for Vitiligo
Integrating Ruxolitinib, Excimer Laser, and Emerging Therapies for Vitiligo

May 30th 2025

Depression Risks in Patients With Vitiligo Vary Significantly by Race and Ethnicity
Depression Risks in Patients With Vitiligo Vary Significantly by Race and Ethnicity

May 26th 2025

Study Supports Dual Approach for Treatment-Resistant Vitiligo
Study Supports Dual Approach for Treatment-Resistant Vitiligo

May 23rd 2025

Latest CME Events & Activities

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Revolutionizing Atopic Dermatitis (RAD) Conference 2025

June 6-7, 2025

Register Now!

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

July 26, 2025

Register Now!

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

View More

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

View More

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

View More

Burst CME: Targeted Therapy for Optimal Psoriasis Management

View More

© 2025 MJH Life Sciences

All rights reserved.